Vir Biotechnology (VIR) Cash from Operations (2018 - 2026)

Vir Biotechnology's Cash from Operations history runs 9 years deep, the most recent figure standing at 132386000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 69.47% year-over-year to 132386000.0; the TTM figure through Mar 2026 stood at 446051000.0 (down 7.46% YoY), while the FY2025 annual figure was 391781000.0, up 12.23% from the prior year.
• Cash from Operations came in at 132386000.0 for Q1 2026 at Vir Biotechnology, down from 25876000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 960136000.0 in Q2 2022 to a low of 389247000.0 in Q2 2023.
• A 5-year average of 5061823.53 and a median of 107927000.0 in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations surged 714.43% in 2022 and tumbled 407.26% in 2023, its largest moves.
• Vir Biotechnology's Cash from Operations stood at 35126000.0 in 2022, then sank by 407.26% to 107927000.0 in 2023, then increased by 18.8% to 87635000.0 in 2024, then soared by 70.47% to 25876000.0 in 2025, then slumped by 411.62% to 132386000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 132386000.0, 25876000.0, and 167570000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison